Back to search

Article

Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy

2023-08-17

Abstract excerpt

<title>Abstract</title> <p>Parkinson's disease (PD) is a debilitating neurodegenerative disease characterized by the loss of midbrain dopaminergic neurons (DaNs) and the abnormal accumulation of α-Synuclein (α-Syn) protein. Currently, no treatment can slow nor halt the progression of PD. Multiplications and mutations of the α-Syn gene (SNCA) cause PD-associated syndromes and animal models that overexpress α-Syn r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
aa096de6-c6f1-5d49-91ec-6e766a3d34ae
DOI
10.21203/rs.3.rs-3182457/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyDOI 10.21203/rs.3.rs-3182457/v1
Select a neighboring publication to make it the new centre.